Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Thymus Lymphoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Malignant Thoracic Neoplasm
Malignant Thymus Neoplasm
Thymus Lymphoma

Hematologic Malignancy

Thymus Lymphoma

CI-CAN-00004112Explore in graph →

Hematologic58 active trials1 approved drugs

NCIt: C6451

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials127
Research
Rankings
Sources & provenance

Data completeness3 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (no data yet)
Evidence (no data yet)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A lymphoma that arises from the thymus. Representative examples include mediastinal (thymic) large B-cell lymphoma and Hodgkin lymphoma.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Malignant Thymus NeoplasmSubtype
Mediastinal LymphomaHematologic Malignancy

Children (3)

ncit

Primary Mediastinal Large B-Cell Lymphoma2 sub
Thymus Hodgkin Lymphoma
Thymus Mucosa-Associated Lymphoid Tissue Lymphoma

5 descendants in total; counters on this page aggregate over all of them.

Anatomy

Anatomical sites

Hematopoietic and Lymphatic SystemC35813
ThoracicC3406

Record

Identity

CancerIndex ID: CI-CAN-00004112
Entity type: Hematologic Malignancy
Malignant: Yes
Solid / hematologic: Hematologic
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 5
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active): 127 / 58

Publications (all / 5y)

654 / 46

Evidence items

0

Genes / variants

0 / 0

Drugs (any / approved)

0 / 1

Genomic cohorts

0

Epidemiology / survival obs.

0 / 0

Data updated 5 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (4)

Lymphoma of the Thymussynonym · NCIt
Lymphoma of Thymussynonym · NCIt
Primary Thymic Lymphomasynonym · NCIt
Thymic Lymphomasynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials58countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #265 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials33countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #247 of 1,284 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items0countaccepted CIViC items · entity + descendantscivicComputednot in a current ranking snapshot
Publications, last 12 months6countPubMed records · stored query · 12-month windowpubmedComputedrank #1196 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts0countopen GDC projects · entity + descendantsgdcComputednot in a current ranking snapshot

Data updated 5 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants